MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
4.240
+0.100 (2.42%)
At close: Dec 20, 2024, 4:00 PM
4.241
0.00 (0.01%)
After-hours: Dec 20, 2024, 4:01 PM EST
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $438.50 million as of December 20, 2024. Its market cap has decreased by -12.59% in one year.
Market Cap
438.50M
Enterprise Value
311.39M
1-Year Change
-12.59%
Ranking
Category
Stock Price
$4.24
Market Cap Chart
Since the IPO on November 27, 2018, MaxCyte's market cap has increased from $130.79M to $438.50M, an increase of 235.27%. That is a compound annual growth rate of 22.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 480.54M |
| Theravance Biopharma | 478.47M |
| InnovAge Holding | 478.16M |
| Alumis | 469.54M |
| Ginkgo Bioworks Holdings | 466.06M |
| AnaptysBio | 456.43M |
| MeiraGTx Holdings | 456.42M |
| Zevra Therapeutics | 455.83M |